NATIONAL HEALTHCARE CORP·4

Jun 10, 4:24 PM ET

ADAMS ROBERT G 4

4 · NATIONAL HEALTHCARE CORP · Filed Jun 10, 2026

Research Summary

AI-generated summary of this filing

Updated

National Healthcare (NHC) Director Robert G. Adams Exercises Options, Gifts Shares

What Happened

  • Robert G. Adams, a director of National Healthcare Corp (NHC), exercised 4,000 stock options on 2026-06-08 at a $69.19 strike price, paying $276,760 to acquire the shares. He then disposed of (gifted) those 4,000 shares the same day. There is no record of an open‑market sale; this was an exercise followed by a gift.

Key Details

  • Transaction date: 2026-06-08
  • Actions and codes: M = Option exercise (acquired 4,000 shares at $69.19; $276,760); G = Gift (disposed 4,000 shares at $0.00)
  • Footnotes: F1 — Options were granted under the 2020 Omnibus Equity Incentive Plan (grant date May 5, 2022); grant and exercise exempt from Section 16(b) under Rule 16b-3(d). F2 — Form notes total beneficial ownership after these transactions (number not provided here).
  • Filing timeliness: Filed 2026-06-10 for a 2026-06-08 transaction (appears timely under Form 4 rules).

Context

  • For options: Adams paid the exercise price in cash ($69.19 per share) to obtain the shares; the shares were then gifted rather than sold, so this is not a market sale signal. Gifts are transfers for personal or tax/relation reasons and do not necessarily indicate the insider’s view on the company’s stock.

Insider Transaction Report

Form 4
Period: 2026-06-08
Transactions
  • Exercise/Conversion

    Shares of Common Stock - Trust I

    [F1]
    2026-06-08$69.19/sh+4,000$276,76017,579 total(indirect: By Trust)
  • Gift

    Shares of Common Stock - Trust I

    [F2]
    2026-06-084,00013,579 total(indirect: By Trust)
  • Exercise/Conversion

    Option to Purchase Common Stock [2022 Grant]

    [F1]
    2026-06-084,0003,500 total
    Exercise: $69.19From: 2023-05-05Exp: 2027-05-04Common Stock (7,500 underlying)
Holdings
  • Shares of Common Stock - Partnership

    (indirect: General Partner)
    430,341
  • Option to Purchase Common Stock [2023 Grant]

    Exercise: $55.75From: 2024-05-04Exp: 2028-05-03Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2024 Grant]

    Exercise: $96.03From: 2025-05-09Exp: 2029-05-08Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2025 Grant]

    Exercise: $94.66From: 2026-05-08Exp: 2030-05-07Common Stock (7,500 underlying)
    7,500
  • Option to Purchase Common Stock [2026 Grant]

    Exercise: $171.42From: 2027-05-07Exp: 2031-05-06Common Stock (7,500 underlying)
    7,500
Footnotes (2)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]Total amount of shares beneficially owned following transactions reported on this form.
Signature
/s/ Robert Adams|2026-06-10

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4